Stock Track | Novavax Plummets 5.19% Amid Broader Vaccine Market Sell-Off

Stock Track

Jan 08, 2025

Novavax Inc., a biotechnology company that develops vaccines for serious infectious diseases, saw its stock plummet 5.19% during intraday trading on Wednesday. This decline comes despite an initial premarket rally spurred by the recent CDC report on rising COVID-19 and flu cases across the United States.

The sell-off in Novavax's shares seems to be part of a broader market correction in the vaccine sector. Major vaccine makers like Moderna, Novo Nordisk, CureVac, and BioNTech, which initially rallied on the CDC's respiratory illness data, also experienced a pullback during intraday trading.

While the CDC's warning of increased COVID-19 and flu activity initially boosted investor confidence in vaccine manufacturers, it appears that the market has now priced in this news, leading to profit-taking and a subsequent decline in stock prices for companies like Novavax.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1129407488"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129407488\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129407488?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-08 22:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129407488","market":"us","top_or_hot":-1,"title":"Stock Track | Novavax Plummets 5.19% Amid Broader Vaccine Market Sell-Off","media":"Stock Track","content":"<p>Novavax Inc., a biotechnology company that develops vaccines for serious infectious diseases, saw its stock plummet 5.19% during intraday trading on Wednesday. This decline comes despite an initial premarket rally spurred by the recent CDC report on rising COVID-19 and flu cases across the United States.</p>\n\n<p>The sell-off in Novavax's shares seems to be part of a broader market correction in the vaccine sector. Major vaccine makers like Moderna, Novo Nordisk, CureVac, and BioNTech, which initially rallied on the CDC's respiratory illness data, also experienced a pullback during intraday trading.</p>\n\n<p>While the CDC's warning of increased COVID-19 and flu activity initially boosted investor confidence in vaccine manufacturers, it appears that the market has now priced in this news, leading to profit-taking and a subsequent decline in stock prices for companies like Novavax.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Novavax Plummets 5.19% Amid Broader Vaccine Market Sell-Off</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Novavax Plummets 5.19% Amid Broader Vaccine Market Sell-Off\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-01-08 22:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax Inc., a biotechnology company that develops vaccines for serious infectious diseases, saw its stock plummet 5.19% during intraday trading on Wednesday. This decline comes despite an initial premarket rally spurred by the recent CDC report on rising COVID-19 and flu cases across the United States.</p>\n\n<p>The sell-off in Novavax's shares seems to be part of a broader market correction in the vaccine sector. Major vaccine makers like Moderna, Novo Nordisk, CureVac, and BioNTech, which initially rallied on the CDC's respiratory illness data, also experienced a pullback during intraday trading.</p>\n\n<p>While the CDC's warning of increased COVID-19 and flu activity initially boosted investor confidence in vaccine manufacturers, it appears that the market has now priced in this news, leading to profit-taking and a subsequent decline in stock prices for companies like Novavax.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVAX","symbol_name":"诺瓦瓦克斯医药","start_time":0,"source_url":"","article_id":"1129407488","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129407488","pubTimestamp":1736346987,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Novavax Inc., a biotechnology company that develops vaccines for serious infectious diseases, saw its stock plummet 5.19% during intraday trading on Wednesday. This decline comes despite an initial premarket rally spurred by the recent CDC report on rising COVID-19 and flu cases across the United States.The sell-off in Novavax's shares seems to be part of a broader market correction in the vaccine sector. Major vaccine makers like Moderna, Novo Nordisk, CureVac, and BioNTech, which initially ral","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"translate_title":"由于更广泛的疫苗市场抛售，Novavax股价暴跌5.19%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":1},"content_text":"Novavax Inc., a biotechnology company that develops vaccines for serious infectious diseases, saw its stock plummet 5.19% during intraday trading on Wednesday. This decline comes despite an initial premarket rally spurred by the recent CDC report on rising COVID-19 and flu cases across the United States.\nThe sell-off in Novavax's shares seems to be part of a broader market correction in the vaccine sector. Major vaccine makers like Moderna, Novo Nordisk, CureVac, and BioNTech, which initially rallied on the CDC's respiratory illness data, also experienced a pullback during intraday trading.\nWhile the CDC's warning of increased COVID-19 and flu activity initially boosted investor confidence in vaccine manufacturers, it appears that the market has now priced in this news, leading to profit-taking and a subsequent decline in stock prices for companies like Novavax.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}